PROFESSIONAL EDITION

The largest community of pharma leaders

FEATURED WRITERS ARTICLES

COVID-19 Statics

All countries
117,593,143
Total confirmed cases
Updated on March 8, 2021 5:26 pm

COVID-19 Statics

All countries
2,607,824
Total deaths
Updated on March 8, 2021 5:26 pm

COVID-19 Statics

All countries
93,063,766
Total recovered
Updated on March 8, 2021 5:26 pm

Shannon Thyme Klinger Joins Moderna as Chief Legal Officer...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna Inc., Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today...

Axial Therapeutics Promotes A. Stewart Campbell to Chief Executive...

WOBURN, Mass.--(BUSINESS WIRE)--Axial Therapeutics Inc., a clinical-stage biopharmaceutical company focused on leveraging the gut-brain axis for the discovery and...

Nathalie Doize Appointed Director of Operations – Rudolph Rosenberg...

PARIS--(BUSINESS WIRE)--Today, Excelya has announced that it has appointed Nathalie Doize as Director of Operations and Rudolph Rosenberg as...

Greenwich LifeSciences Hires Industry Expert, Dr. Jaye Thompson, to...

STAFFORD, Texas--(BUSINESS WIRE)--Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GP2,...

Must Read

The Ethical Data Dilemma

As a globally minded business person, if you haven’t gained exposure to the numerous new laws and regulations emphasizing the rights of people to access, understand and be familiar with their personal data in the last six months, then you must have been living on another planet outside of...

EMA Advises Use of AbCellera-Discovered Bamlanivimab, Alone or Together...

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for...

U.S. FDA Approves Yescarta® for Relapsed or Refractory Follicular...

SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA)...

BeiGene Announces Acceptance of a Supplemental Biologics License Application...

BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing...

Exicure Granted Orphan Drug Designation by the U.S. Food...

CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic...

EDITOR´S PICK

Moderna Announces Supply Agreement to Provide 13 Million Doses of COVID-19 Vaccine Moderna to the Philippines

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a supply agreement with the Government...

Moderna Announces New Drug Application Submitted to Import and Distribute Moderna’s COVID-19 Vaccine Candidate in Japan

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Takeda Pharmaceutical Co., Ltd (NYSE:...

U.S. FDA Expands Approval of Pfizer’s LORBRENA® as First-Line Treatment for ALK-Positive Metastatic Lung Cancer

NEW YORK--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s (NYSE: PFE) supplemental New Drug Application (sNDA) for LORBRENA® (lorlatinib), expanding the...

Iktos Announces Collaboration With Pfizer in AI for Drug Design

PARIS--(BUSINESS WIRE)--Iktos announced today the application of Iktos Artificial Intelligence technology for de novo design to selected Pfizer small-molecule discovery programs. Over the last few...

McKesson Begins Distributing the Johnson & Johnson COVID-19 Vaccine

IRVING, Texas--(BUSINESS WIRE)--As a centralized distribution partner for the U.S. government’s COVID vaccine distribution effort, McKesson today began distributing the COVID-19 vaccine received from...

INDUSTRY NEWS

EMA Advises Use of AbCellera-Discovered Bamlanivimab, Alone or Together with Etesevimab, to Treat Confirmed COVID-19 Patients

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued...

Covid-19: MedinCell Publishes an Extensive Ivermectin Safety Expert Analysis

MONTPELLIER, France--(BUSINESS WIRE)--MedinCell (Paris:MEDCL): No safety concern is anticipated that would prevent health authorities from assessing the use of Ivermectin against Covid-19 as a new...

Genentech’s Actemra Becomes the First Biologic Therapy Approved by the FDA for Slowing the Rate of Decline in Pulmonary Function in Adults With Systemic...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug...

Merck Begins Tender Offer to Acquire Pandion Therapeutics

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer...

Apollomics, Inc Doses First Patient in Phase 1 Clinical Trial in China of GlycoMimetics’ Uproleselan for the Treatment of AML

ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics (Nasdaq: GLYC) today announced that Apollomics has dosed the first patient in China in a Phase 1 clinical trial of APL-106...

Amgen to Acquire Five Prime Therapeutics for $1.9 Billion in Cash

THOUSAND OAKS, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Amgen (NASDAQ: AMGN) and Five Prime Therapeutics (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing...

Gilead Sciences Completes Acquisition of MYR GmbH

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire MYR GmbH for up to...

Contentsquare Partners With Leading Pharmaceutical and Biotech Businesses to Help Manage the Accelerated Shift to Digital Healthcare

NEW YORK--(BUSINESS WIRE)--Contentsquare, the leading experience analytics company, is partnering with leaders in the pharmaceutical and biotech sector to help manage the accelerated shift...

NEWSLETTERS

Check out our Newsletter page - choose the one that fits your needs!

LOOK WHO IS ON THE MOVE

Don't be the last one to know. Subscribe to our weekly newsletter.

EDITOR´S PICK

Receive the best information to your inbox.

FEATURED WRITER

Read what the top minds in pharma have to say!

WEBINARS & WHITEPAPERS